September 5, 2025

Novartis Signs $2.2 Billion Deal with Arrowhead to Develop RNAi Therapy Targeting Alpha-Synuclein in Parkinson’s Disease – geneonline.com

September 5, 2025

Artist with Parkinson’s Boosts Dopamine Via Distinctive Works – Santa Fe New Mexican

September 5, 2025

A blood-based DNA damage signature in patients with Parkinson’s disease is associated with disease progression – Nature

September 5, 2025

Gut microbial production of imidazole propionate drives Parkinson’s pathologies – Nature

September 4, 2025

Brett Favre’s Parkinson’s announcement stuns NFL world as Deanna Favre’s reaction reveals painful truth – Times of India